Showing results (191-200 of 1,297) with videos related to
Sort By:
Pageof 130
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 DiabetesMark E Cooper, Vlado Perkovic, Janet B McGill, et al.American Journal of Nephrology|July 26, 2014
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathyHala Yamout, Vlado Perkovic, Melanie Davies, et al.Nutrition & Diabetes|January 19, 2018
Associations between body mass index and the risk of renal events in patients with type 2 diabetesKamel Mohammedi, John Chalmers, William Herrington, et al.Journal of Hypertension|December 13, 2018
Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuriaMark E Cooper, Vlado Perkovic, Per-Henrik Groop, et al.Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.Social Science & Medicine (1982)|March 21, 2007
The use of psychosocial criteria in Australian patient selection guidelines for kidney transplantationKate Anderson, Alan Cass, Joan Cunningham, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 14, 2009
The RENAL (Randomised Evaluation of Normal vs. Augmented Level of Replacement Therapy) study: statistical analysis planSimon Finfer, Alan Cass, Martin Gallagher, et al.International Journal for Equity in Health|April 20, 2012
If you can't comply with dialysis, how do you expect me to trust you with transplantation? Australian nephrologists' views on indigenous Australians' 'non-compliance' and their suitability for kidney transplantationKate Anderson, Jeannie Devitt, Joan Cunningham, et al.Kidney International|May 30, 2020
Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetesJingWei Li, Bruce Neal, Vlado Perkovic, et al.Nephrology (Carlton, Vic.)|August 13, 2015
Survival outcomes of supportive care versus dialysis therapies for elderly patients with end-stage kidney disease: A systematic review and meta-analysisCeline Foote, Sradha Kotwal, Martin Gallagher, et al.Pageof 130